Conclusion: Isolated ultrasound finding of absent nasal bone has got insignificant chances of down syndrome and trisomies
INTRODUCTION
India and other developing nations facing a rising incidence of non cmmunicable diseases Though among the non communicable diseases genetic disorders a rare occurrence ,there is a rising trend in genetic disorders especially Down syndrome due to late age of marriage and conception .Due to the high birth rate in India ,a very large number of infants with genetic disorders are born every year about half a million with malformations and 21,000 with Down syndrome. The frequency of Down syndrome among 94,610 births was 0.87 per 1000, or 1 per 1150. The children with Down syndrome can develop many complications like heart defects, intestinal abnormalities like Duodenal ateria, Thyroid problems, Leukemia. Hearing loss, Vision problems. Respiratory problems like pulmonary hypertension, Alzheimer's disease .As the result the childrens with Down syndrome pose a big financial and social burden to nation and family. Hence identifying down syndrome in antenatal ultrasound is foremost importance . Karyotyping is gold standard for diagnosis but it is invasive test with a small risk of fetal loss . Nuchal translucency values varies with gestation's age and there is more chance of error in measurement due to subjective variation .Hence in this study we are evaluating the absent nasal bone alone can be significant in diagnosing trisomies , because chances of error is less as there is no measurement and it is non invasive test 1.a Serum markers: The (ACOG) has developed guidelines where women of 35 years and older are typically considered to be at highest risk are offered chorionic villous sampling (CVS) or genetic counseling and amniocentesis , whereas women younger than 35 can be screened using quadruple test with detection rate for Down syndrome to about 80 percent. PAPP-A and HCG measurements are effective for screening only in the first trimester, and alpha-fetoprotein, unconjugated estriol, and inhibin are useful only in the second trimester .In early pregnancy [ 10 weeks] non-invasive maternal serum fetal cell free (cfDNA) is highly sensitive and specific test and reporting also is simple [ very high or very low risk]. serum markers in quadruple test are serum alpha fetoprotein, serum estradiol ,serum B HCG and serum inhibin Alpha-Fetoprotein (AFP ) -AFP is initially produced in the fetal yolk sac and liver. A small amount also is produced by the gastrointestinal tract. By the end of the first trimester, nearly all of the AFP is produced by the fetal liver..The AFP concentration in maternal serum rises throughout pregnancy, from a nonpregnancy level of 0.2 to about 250 ng/mL at 32 weeks gestation.AFP is elevated in open NTD,omphalocele, gastroschisis, congenital renal disease, esophageal atresia, and other fetal distress situations such as threatened abortion, fetal demise and multiple pregnancies. Lower maternal serum AFP values is seen in trisomy 21 (Down syndrome) and trisomy 18.
Estriol (uE3) -The principal estrogen hormone during pregnancy, is synthesized by the intact feto-placental unit.. Estriol levels increase during the course of pregnancy. Decreased unconjugated estriol is a marker for Down syndrome and trisomy 18. Low levelsmay also be seen in pregnancy loss, Smith-Lemli-Opitz, and X-linked ichthyosis (placental sulfatase deficiency). Human Chorionic Gonadotropin-The beta subunit determines the unique physiological, biochemical, and immunological properties of hCG. hCG is synthesized by placental cells in very early in pregnancy, and serves to maintain the corpus luteum, and begins to fall as the role of the corpus luteum in maintaining pregnancy diminishes.Increased levels are associated with Down syndrome, while decreased levels may be seen in trisomy 18. Elevations of hCG also can be seen in multiple pregnancies, triploidy, fetal loss, and hydrops fetalis.
Inhibin A -secreted by the feto-placental unit during pregnancy. Maternal inhibin A levels is correlated with maternal hCG levels and are abnormal in the same conditions that are associated with abnormal hCG levels (eg, inhibin A levels are typically higher in Down syndrome pregnancies). Down syndrome -Calculated screen risks <1/270 are reported as screen negative screen risks > or =1/270 are reported as screen positive. Trisomy 18 -Calculated screen risks<1/100 are reported as screen negative, screen risks > or =1/100 are reported as screen positive..
Interpretation
A negative screen does not guarantee the absence of trisomy 18 or Down syndrome. Screen test has detection rate of approximately 77% to 81% of Down syndrome with a false-positive rate of 6% to 7%. and 60% to 80% for trisomy 18. Screening efficiency increases with maternal age. The estimated risk calculations and screen results are dependent on accurate information for gestation, maternal age, race, IDD, and weight. bAneuploidy screening-All women, regardless of age, should be offered aneuploidy screening before 20 weeks' gestation .Screening typically provides information about the patient's age-related risk; serum analyte levels; and, if available, nuchal translucency measurements. A numeric risk assessment allows the patient to determine the risk and consequences of giving birth versus proceeding with diagnostic testing.If the screening test is positive and the patient chooses to proceed with a diagnostic procedure (e.g., CVS, amniocentesis), there is a higher chance of discovering an aneuploid fetus than if the woman had not undergone screening. If screening is done, fewer invasive diagnostic procedures would be needed to find a fetus with aneuploidy, and performing fewer diagnostic tests would reduce the number of procedure-related losses of normal fetuses. First trimester screening is combined screening of nuchal translucency measurements, serum markers [PAPP-A and beta-hCG], and maternal age. Second trimester screening involves quadruple screening and maternal age .Genetic counseling and CVS or second-trimester amniocentesis should be offered to women who are found to have an increased risk of aneuploidy during first-trimester screening. Those who are negative for first trimester screening should be offered second trimester quadriple screening. Women should be offered targeted ultrasonography, fetal echocardiography, or both if they have a fetal nuchal translucency measurement of at least 3.5 mm despite other factors (e.g., negative result on aneuploidy screen, normal fetal chromosomes) because these fetuses are at a significant risk of congenital heart defects, abdominal wall defects, diaphragmatic hernias, and genetic syndromes. Integrated screening is defined as first-and second-trimester screening used to adjust the patient's age-related risk and are reported after both first-and second-trimester tests are done .One trial found that integrated screening using only serum had a detection rate of 85 to 88 percent, however, there is a longer wait time (three to four weeks) between initiation and completion of screening, which may cause increased anxiety for Cicero et al. 13 found that at the 11-14-week scan the nasal bone was absent in 43 of 59 (73%) cases of trisomy 21, while it was absent in only three of 603 (0.5%) chromosomally normal fetuses. The authors found a likelihood ratio of 146.0 for an absent nasal bone. these data are confirmed, the impaired ossification of the fetal nose Sonek and Nicolaides have recently reported three cases of trisomy 21 in the mid-trimester, in which the nasal bone was absent or shorter than expected for the gestational age. They concluded that the measurement of the fetal nose might improve ability to detect Down syndromee will prove to be one of the most specific markers for trisomy 21. In a study on association between first trimester absence of fetal nasal bone on ultrasound and Down syndrome by, Igarzábal L, Matayoshi T, Gadow EC. showed that absence of nasal bone by first trimester ultrasound was significantly associated with Down syndrome. nasal bone was visible in more than 99% of karyotypically normal fetuses. 2169 singleton fetus from January 2002 to February 2005, by measuring nasal bone length in 2169 singleton fetuses on a midsagittal plane at 12-14 weeks' gestation.The nasal bone length measurement showed a significant increase with gestational age (GA) (p < 0.05). A linear relationship between nasal bone length and gestational age (NBL = -3.3462 x GA + 0.627, R(2) = 0.30, p < 0.001) as well as a linear relationship between nasal bone length and crown-rump length (CRL) (NBL = 0.3741 x CRL + 0.284, R(2) = 0.30, P < 0.001) was established. In a study of Integrated ultrasound and biochemical screening for trisomy 21 using fetal nuchal translucency, absent fetal nasal bone, free beta-hCG and PAPP-A at 11 to 14 weeks.by Bindra R, Rembouskos G, Nicolaides KH,they concluded that integrated sonographic and biochemical test at 11 to 14 weeks can potentially identify about 90% of trisomy 21 fetuses for a false-positive rate of 0.5%.The nasal bone was absent in 69% and present in 31 %of the trisomy 21 fetuses suggesting that absent fetal nasal bone alone is 69% sensitive detection of chromosomal anomalies In a study of first-trimester nuchal translucency, nasal bones,and trisomy 21 in selected and unselected populations .they concluded that First-trimester nasal bones assessment for trisomy 21 screening has a very different performance in selected and unselected pregnancies .The sensitivity, specificity, positive and negative predictive value of absent nasal bones for trisomy 21 were 16.7%, 97.3%, 1.1%, 99.8% and 47.6%, 95.3%, 33.3%, 97.4% in the unselected and selected population, respectively.
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III.
Materials And Methods The study was conducted in our institution. We selected patients who come for NT scan between 11-to 13.6 weeks for our we used GE voluson ultrasound for our study with curvilinear probe with 3.5 to 5MZ . we included all the antenatal mother referred for nuchal tranlucency scan in our study . Age of the mothers were between 22 and 38 years and the average age is 32 years .mothers were informed about the study. Mothers with hypoplastic nasal bone and/or absent nasal bone were further referred for serum markers like serum PAPPA,B HCG if the mother comes in first trimester and quadruple test if the motehr comes in the second trimester and later confirmed with karyotyping by aspirating aminiotic fluid / chorionic villous sampling . Mothers with normal NT scan and nasal bone were further evaluated with serum markers ,but karyotyping was not done because almost all of them did not give consent for invasive procedure of karyotyping as the chances of losing pregnancy is present in these invasive tests,whereas the mothers with fetus having absent or hypoplastic nasal bone and increased nuchal translucency gave consent as it was the confirmatory test for diagnosis and also to know the trisomy type. In addition of nuchal translucency and nasal bone, other soft markers and major congenital anomalies also screened during the same scan but not considered in our study.
All the antenatal nuchal translucency and nasal bone assessment was done by transabdominal method The gestational period must be 11 to 13+6 weeks or CRL between 45-84mms.The magnification of the fetus must be such that only the head and upper thorax are present on the screen.A mid sagittal section of the fetal profile is obtained with the ultrasound transducer held parallel to the direction of the nose. The echogenicity of the nasal bone should be greater that the skin overlying it. we usually see 3lines if the position is correct .The first two lines, which are proximal to the forehead, are horizontal and parallel to each other, resembling an equal sign •. The top line represents the skin and bottom one, which is thicker and more echogenic than the overlying skin, represents the nasal bone.A third line, almost in continuity with the skin, but at a higher level, represents the tip of the nose.Absence of the bottom line of the equals sign represents the absence of the nasal bone.When the nasal bone line appears as a thin line, less echogenic than the overlying skin, it suggests that the nasal bone is not yet ossified, and it is therefore classified as being absent. In our study we screened for nuchal transluceny as the patient for it only. The following chart to assess the translucency which is based on the standard reference 
IV. Results
Out of 1546 studies, 15 cases showed abnormality and 1531 cases were normal sonographically Most of the mothers who showed abnormality were more than 30 years.Out of 15 abnormal sonography, 8 of them showed both absent nasal bone and increased nasal translucency for the given CRL, 3 mothers showed isolated increased nasal translucency with bone, 4 of them showed absent nasal bone with normal nuchal translucency.Amniotic fluid analysis was performed for karyotyping in all 15 of the cases . Out of 15 cases , 11 cases showed abnormality with trisomy 21 in 9 cases and other trisomy in 2 cases .Out of 11cases ,7 cases are absent nasal bone and increased translucency,2 cases are isolated nuchal tranlucency and 2 cases are isolated absent nasal bone showed trisomies. 1 case of increased nasal translucency and
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DOI: 10.9790/0853-1610015360 www.iosrjournals.org 58 | Page absent nasal bone,2 cases of isolated absent nasal bone fetuses and 1 of the increased translucency case showed normal karyotyping. Out of 15 abnormal cases , 10 patients showed abnormal quadraple test. 7 cases of increased nuchal translucency and absent nasal bone , 2 cases of increased nuchal translucency and 1 case of isolated nasal bone showed high risk for trisomies in quadruple test .Statistical analysis showed when isolated nuchal tranlucency is considered for diagnosing trisomies by comparing with karyotyping the P value is 0.564 suggesting that there is no stastistical significance. Though isolated nuchal transluceny patients shows 66% chance for diagnosing trisomies which is better when compared to patients without any ultrasound finding or with isolated nasal bone in diagnosing trisomies , it is not statistically significant. From the analysis it is clear that the combined ultrasound finding of increased nasal translucency and absent nasal bone shows significant P value with 87.5% of cases showing karyotype positivity and indirectly increased chances of trisomies and Down syndrome,whereas isolated ultrasound finding of either increased nasal translucency or absent nasal bone shows insignificant P value suggesting that though there is difference between these isolated ultasound finding and those without any ultrasound finding, difference is insignificant From the analysis it is clear that the chances of karyotype positivity increases with maternal age V. Discussion The risk of down syndrome can be calculated based on maternal age, nuchal translucency thickness and blood investigations between 10-13 weeks and 15-20 weeks of gestation .some of the key markers like evaluation of nasalbone, linear arrangement of AV valves ,short femur and humerus relative to head size ,fetal hydronephrosis, echogenic intracardiac focus.increased nuchal fold thickness alone can diagnose trisomies . it calculates the risk of trisomies .when in addition to increased nuchal fold thickness ,quad test is positive the risk multiplies by 17 times. Non ossified nasal bone and linear arrangement of AV valves increases the risk by 30-60.The incidence of absent nasal bone related to NT,CRL , ethnic origin and aneuploidy.The software first calculates risk based on maternal age,fetal nuchal translucency and maternal serum markers.If the risk is 1 in 50 and if the nasal bone is present ,the risk does not change .If the risk is between 1in 50 -1000 and if the nasal bone is present ,the risk usually reduces and if nasalbone is absent the risk increases.isolated nasalbone absence shows no significant risk. From our study it is clear that isolated nasal bone absence shows insignificant risk and risk is significant if associated with increased nasal translucency
VI.
Conclusion Combined ultrasound finding of increased nasal translucency and absent nasal bone fetuses have more and significant chances of trisomies and Down syndrome .Isolated ultrasound finding of either increased nasal translucency or absent nasal bone has got insignificant chances of down syndrome and trisomies .Down syndrome and trisomies increases with maternal age is again proved by this study .Fetuses with more increased NT thickness has got more chances of trisomies and Down syndrome 
